Login to Your Account



Crucell, Harvard's Adenoviral Vector Work Gets $19M Grant

By Jennifer Boggs


Tuesday, August 2, 2005
Crucell NV's ongoing collaboration with Harvard Medical School to develop vaccine technology using adenovirus-based vectors received a $19.2 million boost from the National Institutes of Health. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription